Moderna stock chart.

At close: 04:00PM EST. Trade prices are not sourced from all markets. 30,620,631. Find the latest Pfizer Inc. (PFE) stock quote, history, news and other vital information to help you with your ...Nov 10, 2022 · Image source: Moderna. In the chart, Moderna's lowest prediction for coronavirus market size is 400 million doses administered at a price of $20 per dose. That would equal a total market size of ... Sep 18, 2023 · Moderna, Inc. Common Stock (MRNA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Nov 2, 2023 · Revenue: $1.83 billion vs. $1.40 billion expected. Moderna posted a net loss of $3.63 billion, or $9.53 per share, for the quarter. That compares with net income of $1.04 billion, or $2.53 per ... Discover historical prices for TGT stock on Yahoo Finance. View daily, weekly or monthly format back to when Target Corporation stock was issued.

What is Moderna's quote symbol? (NASDAQ: MRNA) Moderna trades on the NASDAQ under the ticker symbol MRNA. Moderna stock quotes can also be displayed as NASDAQ: ...

Moderna Inc · 09:00AM, Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools. · 03:11PM, Join thousands of traders who ...

Moderna Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time MRNA stock price.Moderna Stock Forecast $188.40 was a big level going back to February of last year. The stock eventually broke above in summer 2021 and staged a successful pullback test before marching higher.MODERNA AKTIE und aktueller Aktienkurs. Nachrichten zur Aktie Moderna Inc | A2N9D9 | MRNA | US60770K1079 ... Chart-Analyse-Tool: Moderna. Chart-Analyse-Tool öffnen Chart-Analyse-Tool öffnen. May 23, 2023 · Market Cap. $30B. Today's Change. (2.74%) $2.13. Current Price. $79.83. Price as of December 1, 2023, 4:00 p.m. ET. You’re reading a free article with opinions that may differ from The Motley ... MRNA Stock 12 Months Forecast. $123.23. (59.77% Upside) Based on 14 Wall Street analysts offering 12 month price targets for Moderna in the last 3 months. The average price target is $123.23 with a high forecast of $231.00 and a low forecast of $52.00. The average price target represents a 59.77% change from the last price of $77.13.

Other interpretations use crossovers between the red and green lines as market timing signals if the resulting direction of both lines is the same. Going up is bullish, going down is bearish. Technical Analysis Summary for Moderna Inc with Moving Average, Stochastics, MACD, RSI, Average Volume.

The Moderna Spikevax ® COVID-19 vaccine is approved for primary vaccination in people who are 6 months of age and older. Its safety and effectiveness in people younger than 6 months have not yet been established. This vaccine is also approved as a booster for people 12 years of age and older.

Establishing ownership of stock depends on how the stock was purchased, according to the Securities and Exchange Commission. A brokerage firm may have purchased the stock or it may have been bought directly from the company.Discover historical prices for TGT stock on Yahoo Finance. View daily, weekly or monthly format back to when Target Corporation stock was issued.Historical daily share price chart and data for Pfizer since 1972 adjusted for splits and dividends. The latest closing stock price for Pfizer as of November 30, 2023 is 30.47. The all-time high Pfizer stock closing price was 56.72 on December 16, 2021. The Pfizer 52-week high stock price is 54.93, which is 80.3% above the current share price.Moderna, Inc. (NASDAQ:MRNA) issued its earnings results on Thursday, November, 2nd. The company reported ($1.39) EPS for the quarter, beating the consensus estimate of ($2.01) by $0.62. The business earned $1.83 billion during the quarter, compared to analysts' expectations of $1.37 billion.Further, Moderna stock filled the last of its major gaps on the chart, at $109.29. If Moderna closes below Tuesday's low, it puts $103 on the table. Below $103 and a retest of the July high near ...

Moderna Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Today, Moderna’s vaccine has propelled its market capitalization to $67 billion. BioNtech, which later partnered with Pfizer to develop mRNA vaccines, is now valued at over $46.33 billion (see market chart at the bottom of this page). Both the Moderna and Pfizer/BioNTech vaccines use mRNA technology.Moderna's advanced charting and technical analysis tool lets you customize your analysis with a wide range of studies and indicators, including Moving Averages (SMA and EMA), MACD, On-Balance Volume, Relative Strength Index (RSI), Bollinger Bands, Fibonacci Lines, and more. You can also access unique indicators from TipRanks, such as analyst ... Stock charts help investors understand how stock prices change over time. They are indispensable tools for anyone who invests in the stock market. Reading a stock chart shows you the present and ...Find the latest MFA Financial, Inc. (MFA) stock quote, history, news and other vital information to help you with your stock trading and investing.

The all-time high Moderna stock closing price was 484.47 on August 09, 2021. The Moderna 52-week high stock price is 217.25, which is 172.1% above the current share price. The Moderna 52-week low stock price is 62.55, which is 21.6% below the current share price. The average Moderna stock price for the last 52 weeks is 131.03.

At Moderna, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below.Interactive Chart. Interactive Charts provide the most advanced and flexible platform for analyzing historical data, with over 100 customizable studies, drawing tools, custom spreads and expressions, plus a wide range of visualization tools. While logged into the site, you will see continuous streaming updates to the chart.Investor Relations Overview. Deliver on the promise of mRNA science to create a new generation of transformative medicines for patients. Overview of Moderna news, events & presentations, latest quarterly results, and Moderna's pipeline development programs.Feb 14, 2022 · Surprising Fact. Monday's worst-performing stock in the S&P 500, Moderna has plunged 72% from an all-time closing high of $484 on August 9, wiping out more than $140 billion from the firm’s ... CAMBRIDGE, MA / ACCESSWIRE / May 11, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that its recently appointed Chief Financial Officer, Jorge Gomez, has departed the Company, effective immediately. The …Find the latest historical data for Moderna, Inc. Common Stock (MRNA) at Nasdaq.com. ... Charts Live; NEWS & ANALYSIS. News Live; ... Get up to 10 years of daily historical stock prices & volumes. Moderna is expected to post a loss of $3.97 per share for the current quarter, representing a year-over-year change of -175.8%. Over the last 30 days, the Zacks Consensus Estimate has changed -9.9 ...

If you bought $2,500 worth of Moderna's shares at the start of January 2019, just a month after its initial public offering (IPO), you'd now have around $22,550 after experiencing ginormous gains ...

Pharmaceutical stocks Pfizer, GSK, Moderna and J&J are advancing toward successful RSV vaccines, and the first FDA ruling is drawing near. After years of lab failures, the companies could crack ...

MRNA Earnings Date and Information. Moderna last issued its quarterly earnings data on November 2nd, 2023. The reported ($1.39) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($2.01) by $0.62. The company earned $1.83 billion during the quarter, compared to analysts' expectations of $1.37 billion.Overview Stock Screener Earnings Calendar Sectors Nasdaq | MRNA U.S.: Nasdaq Moderna Inc. Watch list NEW Set a price target alert Open Last Updated: Dec 1, 2023 …Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases. In depth view into MRNA (Moderna) stock including the latest price, news, dividend history, earnings information and financials. Interactive Chart for Moderna, Inc. (MRNA), analyze all the data with a huge range of indicators. The Moderna Spikevax ® COVID-19 vaccine is approved for primary vaccination in people who are 6 months of age and older. Its safety and effectiveness in people younger than 6 months have not yet been established. This vaccine is also approved as a booster for people 12 years of age and older.March 14, 2022. CAMBRIDGE, MA / ACCESSWIRE / March 14, 2022 / Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the first participant has been dosed in a clinical trial of an experimental human immunodeficiency virus (HIV) trimer mRNA …Moderna, Inc.'s (NASDAQ:MRNA) Intrinsic Value Is Potentially 92% Above Its Share Price. Get the latest Moderna, Inc. (MRNA) stock news and headlines to help you in your trading and investing ...The South Korean government is in talks with Moderna (MRNA) and Pfizer (PFE) about manufacturing their COVID-19 vaccines in the country, according to a Reuters report. The world faces a limited supply of COVID-19 vaccine doses, and South Korea has the ambition of becoming a vaccine manufacturing hub. To address the supply shortages …Stock Split. P. Candlestick Patterns. To hide/show event marks, right click anywhere on the chart, and select "Hide Marks On Bars". See how it's done ». Chart Manual. Real-time charting tool that ...Miraculous price movement Moderna looks ready to take on the world, with the efficacy of its new cancer vaccine turning heads. Shares in Moderna skyrocketed by almost 20% yesterday in its biggest single day price jump of the year. The pharmaceutical company has managed to weather 2022 market conditions without too drastic a drop, but …

Shares of Moderna (MRNA 2.21%) jumped 8.4% on Friday after rival drugmaker Pfizer (PFE 0.23%) said it intends to drastically increase the price of its COVID-19 vaccine next year. So what04:05 PM ET 05/04/2023. Moderna ( MRNA) stock jumped Thursday on an unexpected first-quarter gain even as sales plummeted amid waning demand for Covid vaccines. During the first quarter, Moderna ...Investor Relations Overview. Deliver on the promise of mRNA science to create a new generation of transformative medicines for patients. Overview of Moderna news, events & presentations, latest quarterly results, and Moderna's pipeline development programs.Instagram:https://instagram. workers comp cost calculatorvanguard high dividend etfis amazon a buy right nowo'reilly share price Moderna, Inc. is a clinical-stage pharmaceutical company, primarily focused on discovering and developing messenger RNA (mRNA) based therapies. The company's mRNA based COVID-19 vaccine, Spikevax (mRNA-1273), is approved for use in adults in the United States. The vaccine is also authorized for emergency use in several countries as COVID-19 ... Jun 26, 2023 · Moderna — The drugmaker gained 2.5% following an upgrade by UBS to buy from neutral.The bank said the stock's current valuation isn't pricing in potential upside from other vaccines. UBS cut its ... best forex vps hostingig demo account CAMBRIDGE, MA / ACCESSWIRE / April 11, 2023 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced clinical and program updates demonstrating expansion and advancement of its mRNA pipeline. The updates include advancements in the Company's respiratory and latent virus ...Shares in Moderna were down 2.3% in premarket trading on Wall Street after the decision was announced by BioNTech earlier on Tuesday. Find the latest BioNTech SE (BNTX) stock quote, history, news ... vym dividend dates Meet our executive team & Board of Directors who are committed to solving the world’s diseases with mRNA technology.These 10 analysts have an average price target of $163.0 versus the current price of Moderna at $159.68, implying upside. Below is a summary of how these 10 analysts rated Moderna over the past 3 ...Jun 26, 2023 · Moderna — The drugmaker gained 2.5% following an upgrade by UBS to buy from neutral.The bank said the stock's current valuation isn't pricing in potential upside from other vaccines. UBS cut its ...